Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Diatron Launches Intelligent Walk-away Analyzer at Medica
Monday, October 13, 2014
The P500 offers cost-effective bench top automation for clinical chemistry.

Mobidiag Announces CE-IVD Marking of Amplidiag™ Bacterial GE
Thursday, September 25, 2014
Test optimizes screening of gastroenteritis-causing bacteria directly from stool samples.

Seward Secures Strong Environmental Credentials Through ISO14001 Certification
Friday, September 19, 2014
Maximizing recycling and minimizing energy usage and environmental impact.

HORIBA UK Introduces EasyCell® Assistant Digital Cell Imaging System
Friday, September 19, 2014
Fast and affordable automated cell imaging to improve lab productivity.

Microvisk: ‘World First’ Medical Device Accredited for European Sales
Friday, September 19, 2014
Solid state technology unique in medical diagnostics.

Medimetrics Expands Medical Device Portfolio with New Fast Release IntelliCap
Tuesday, September 16, 2014
The Company wins ISO and EN Certification for its design & development capabilities.

Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
Friday, September 12, 2014
Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices.

Diagnostic Tool for Therapeutic Plasma Medicine
Tuesday, September 09, 2014
HPR-60 mass spectrometer for direct measurement of reactive and gaseous species.

PerkinElmer Launches Innovative Multiplexing System
Thursday, September 04, 2014
AlphaPlex™ reagent technology provides life sciences researchers with more data in less time.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 476
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv